- Clinical Trials
- November 2024
- 893 Pages
Global
From €3086EUR$3,450USD£2,714GBP
- Report
- October 2025
- 196 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- August 2025
- 136 Pages
Global
From €2280EUR$2,549USD£2,006GBP
€2682EUR$2,999USD£2,360GBP
- Report
- June 2025
- 138 Pages
Global
From €2280EUR$2,549USD£2,006GBP
€2682EUR$2,999USD£2,360GBP
- Report
- May 2025
- 120 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- April 2025
- 100 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- October 2025
- 186 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 193 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 180 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- November 2025
- 177 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 162 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 273 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 192 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- September 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- January 2025
- 175 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- March 2025
- 180 Pages
Global
From €4025EUR$4,500USD£3,541GBP
- Report
- October 2025
- 195 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 198 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 191 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 183 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP

Macular Edema is a condition in which fluid accumulates in the macula, the central part of the retina responsible for sharp, central vision. It is a common complication of diabetes, and can also be caused by other diseases or conditions such as uveitis, retinal vein occlusion, and retinopathy of prematurity. Treatment options for macular edema include laser photocoagulation, intravitreal injections, and vitrectomy.
Optical treatments for macular edema include laser photocoagulation, which uses a laser to reduce the amount of fluid in the macula. Intravitreal injections are also used to reduce fluid accumulation, and vitrectomy is a surgical procedure that removes the vitreous gel from the eye and replaces it with a gas bubble.
Companies in the macular edema market include Regeneron Pharmaceuticals, Allergan, Novartis, Roche, and Bayer. Show Less Read more